Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 4/1/2002


1.		Phase II Study of Busulfan and Cyclophosphamide Followed By Autologous Bone Marrow Transplantation Using Marrow Treated with c-myb Antisense Oligodeoxynucleotide in Patients With Chronic or Accelerated Phase Chronic Myelogenous Leukemia (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 60				NCI				UPCC-3492 NCI-H94-0532, NCT00002592

Last Modified: 9/6/2006 First Published: 4/1/1999


2.		Phase I Study of Autologous Bone Marrow Transplantation with c-myb Antisense Oligonucleotide Treated CD34+ Selected Stem Cells Following Chemotherapy in Patients with Chronic Myelogenous Leukemia in First Chronic Phase (Summary Last Modified 10/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 to 60				NCI				E-2996 E2996

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute